Towards the elucidation of the mechanisms underlying breast cancer mutations

The genome of cancer cells is characterized by the presence of somatic mutations acquired during the processes of neoplastic transformation and clonal expansion. A small fraction of these mutations, called drivers, causally affect oncogenesis by conferring growth advantage. The remaining mutations, also called passengers, do not contribute to the advantage of tumor growth (1,2).